CD40 signaling in endothelial cells (EC) constitutes a powerful pro-inflammatory stimulus that is viewed as a hallmark of atherogenesis. It is not clear, though, which cell capable of expressing the corresponding ligand (T cells, platelets) is ultimately responsible for this pro-inflammatory EC activation. Therefore, the project examines the relative extent by which CD40-CD154 driven EC-leukocyte, EC-platelet and/or platelet-leukocyte interactions contribute to the initiation and/or manifestation of atherosclerosis. It focuses on the interaction of type 1 T-helper cells, natural T-regulatory cells and monocyte/macrophages with both endothelial cells and platelets as well as with each other and primarily employ reverse genetics techniques in vitro and in vivo. |